These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8534633)

  • 21. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
    Amarenco G; Adba MA; Kerdraon J
    Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical oxybutynin chloride for relaxation of dysfunctional bladders.
    Brendler CB; Radebaugh LC; Mohler JL
    J Urol; 1989 Jun; 141(6):1350-2. PubMed ID: 2724432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravesical oxybutynin hydrochloride in the treatment of urge incontinence in the elderly].
    Mizunaga M; Miyata M; Kaneko S; Taniguchi N; Yachiku S; Chiba K; Osanai H; Fujisawa M
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):923-7. PubMed ID: 8753011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Abrams P; Cardozo L; Chapple C; Serdarevic D; Hargreaves K; Khullar V;
    Int J Urol; 2006 Jun; 13(6):692-8. PubMed ID: 16834644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of salivary stimulant pastilles to improve compliance in women taking oxybutinin hydrochloride for detrusor instability.
    Arango O
    Br J Urol; 1998 Apr; 81(4):652. PubMed ID: 9598656
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravesical oxybutynin: practicalities of clinical use.
    Guerrero K; Emery S; Owen L; Rowlands M
    J Obstet Gynaecol; 2006 Feb; 26(2):141-3. PubMed ID: 16483973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study.
    Hooper P; Tincello DG; Richmond DH
    Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic effects of intrarectal administration of oxybutynin].
    Radziszewski P; Borkowski A
    Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience.
    Saito M; Watanabe T; Tabuchi F; Otsubo K; Satoh K; Miyagawa I
    Int J Urol; 2004 Aug; 11(8):592-6. PubMed ID: 15285747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ; Cardozo LD; Versi E; Cooper D
    Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxybutynin chloride in the management of idiopathic detrusor instability.
    Paulson DF
    South Med J; 1979 Mar; 72(3):374-5. PubMed ID: 424842
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder.
    Amark P; Eksborg S; Juneskans O; Bussman G; Palm C
    Br J Urol; 1998 Dec; 82(6):859-64. PubMed ID: 9883225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interstitial cystitis: bladder training with intravesical oxybutynin.
    Barbalias GA; Liatsikos EN; Athanasopoulos A; Nikiforidis G
    J Urol; 2000 Jun; 163(6):1818-22. PubMed ID: 10799190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.
    Yarker YE; Goa KL; Fitton A
    Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Moore KH; Goldstein M; Hay D
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy.
    Beiko DT; Watterson JD; Knudsen BE; Nott L; Pautler SE; Brock GB; Razvi H; Denstedt JD
    J Endourol; 2004 Oct; 18(8):723-30. PubMed ID: 15659891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride.
    Madersbacher H; Jilg G
    Paraplegia; 1991 Feb; 29(2):84-90. PubMed ID: 2023781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.